Tuesday, January 10, 2012
-
Going Nuc-lear on Hepatitis C -- Is Idenix the Next Target? (ABT, ACHN, BMY, GILD, IDIX, INHX, JNJ, Long Ideas, MRK, News, NVS, PFE, VRTX, VRUS, Short Ideas, Price Target, Rumors, M&A, Events, Intraday Update, Analyst Ratings, Movers, Trading Ideas / Tue, 03:54pm)
Friday, December 16, 2011
-
Robert W. Baird Downgrades Pharmasset to Neutral (VRUS, Downgrades, Analyst Ratings / Fri, 11:51am)
Monday, December 05, 2011
-
Citi Reiterates Buy, $49 PT on Gilead (Analyst Color, GILD, News, VRUS, Price Target, Reiteration, FDA, Intraday Update, Markets, Analyst Ratings, Movers, Trading Ideas / Mon, 01:11pm)
-
J.P. Morgan Reiterates Overweight On Gilead (Analyst Color, GILD, News, VRUS, Reiteration, FDA, Intraday Update, Markets, Analyst Ratings, Movers, Trading Ideas / Mon, 01:07pm)
Tuesday, November 29, 2011
-
Brean Murray Raises Inhibitex PT to $19 From $12 (Analyst Color, GILD, INHX, Long Ideas, News, VRUS, Price Target, Reiteration, FDA, Intraday Update, Markets, Analyst Ratings, Trading Ideas / Tue, 01:25pm)
Monday, November 28, 2011
-
Deutsche Bank Has Buy, $53 PT On Gilead (Analyst Color, GILD, News, VRUS, Price Target, Reiteration, FDA, M&A, Intraday Update, Markets, Analyst Ratings, Trading Ideas / Mon, 12:37pm)
Tuesday, November 22, 2011
-
End-of-Day Market Summary for November 22, 2011 (BHO, BRCD, CISG, DLB, FMCN, FRO, MRK, News, NUAN, P, SFL, SIRI, STP, TIVO, TLR, VRUS, WIN, Broad U.S. Equity ETFs, Upgrades, Downgrades, Contracts, Legal, Events, Global, Econ #s, Economics, After-Hours Center, Markets, Analyst Ratings, Movers, Tech, Reviews, ETFs / Tue, 05:15pm)
-
Brean Murray Downgrades Pharmasset to "Hold" (Analyst Color, GILD, News, VRUS, Downgrades, Price Target, FDA, M&A, Intraday Update, Markets, Analyst Ratings, Movers, Trading Ideas / Tue, 12:29pm)
-
Brean Murray Downgrades Pharmasset to Hold, Removes PT (VRUS, Downgrades, Price Target, Analyst Ratings / Tue, 11:47am)
-
Leerink Downgrades Pharmasset to Market Perform (VRUS, Downgrades, Pre-Market Outlook, Analyst Ratings / Tue, 08:46am)
-
Canaccord Downgrades Pharmasset to Hold (GILD, VRUS, Downgrades, Pre-Market Outlook, Analyst Ratings / Tue, 08:20am)
-
UBS Downgrades Pharmasset to Neutral (GILD, VRUS, Downgrades, Price Target, Pre-Market Outlook, Analyst Ratings / Tue, 08:19am)
-
Benzinga's Top Downgrades (DOLE, SMP, TSL, VRUS, Downgrades, Analyst Ratings / Tue, 08:04am)
Monday, November 21, 2011
-
Financial Breakfast: Morning News Summary for November 21, 2011 (BYI, Earnings, FSIN, GILD, Long Ideas, MYL, News, REGN, TECD, TGT, TRH, TSN, VRUS, WAL, Y, Futures, Guidance, Short Ideas, Upgrades, Commodities, Downgrades, Forex, Technicals, FDA, M&A, Events, Global, Econ #s, Economics, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, General / Mon, 08:34am)
Tuesday, November 15, 2011
-
Piper Jaffray Reiterates Overweight, $90 PT on Pharmasset (Analyst Color, SVR, VRUS, Reiteration, Analyst Ratings / Tue, 11:07am)
Monday, November 07, 2011
-
Goldman Sachs Raises PT on Pharmasset to $77 (VRUS, Price Target, Analyst Ratings / Mon, 10:22am)
-
Morgan Stanley Maintains Overweight Rating on Pharmassset (Analyst Color, IFN, News, VRUS, Reiteration, FDA, Analyst Ratings / Mon, 08:37am)
-
Piper Jaffray Overweight on Pharmasset (Analyst Color, SVR, VRUS, Price Target, Analyst Ratings / Mon, 08:35am)
Tuesday, November 01, 2011
Friday, October 21, 2011
-
End-of-Day Market Summary for October 21, 2011 (ABT, AH, AMAG, APKT, BAS, CYS, CYT, DCT, EGT, GD, GE, HAR, MCD, News, PENN, RRR, STX, SYNA, VRUS, VZ, Broad U.S. Equity ETFs, Upgrades, Downgrades, Contracts, M&A, Events, Global, Econ #s, Economics, After-Hours Center, Markets, Analyst Ratings, Movers, Tech, ETFs / Fri, 04:14pm)
Thursday, October 13, 2011
-
UBS Changes PT on ADTN, VRUS, SGEN (ADTN, SGEN, VRUS, Price Target, Analyst Ratings / Thu, 11:04am)
Monday, October 03, 2011
-
Bank of America Raises PO on Pharmasset to $102 (VRUS, Price Target, Analyst Ratings / Mon, 06:06am)
Tuesday, September 13, 2011
-
J.P. Morgan Reiterates Pharmasset Overweight (Analyst Color, VRUS, Reiteration, Analyst Ratings / Tue, 09:45am)
Wednesday, September 07, 2011
-
Brean Murray Raises PT On Pharmasset To $105 (VRUS, Price Target, Analyst Ratings / Wed, 05:47am)
Friday, August 12, 2011
-
Citi Reiterates Buy and PT of $200 on Pharmasset (VRUS, Reiteration, Analyst Ratings / Fri, 07:10am)
